Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The Rlign algorithm for enhanced electrocardiogram analysis through heart rate-corrected ECG alignment for explainable classification and clustering.

European heart journal. Digital health·2026
Same author

Implementation and User Evaluation of an On-Premise Large Language Model in a German University Hospital Setting: Cross-Sectional Survey.

JMIR AI·2026
Same author

Response to 'promising advances and remaining challenges in AI-driven QTc estimation' by Zekai Yu.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same author

End-to-End Platform for Electrocardiogram Analysis and Model Fine-Tuning: Development and Validation Study.

Journal of medical Internet research·2026
Same author

Advancements in Renal Imaging: A Comprehensive Systematic Review of PET Probes for Enhanced GFR and Renal Perfusion Assessment.

Diagnostics (Basel, Switzerland)·2025
Same author

QTcNet: a deep learning model for direct heart rate corrected QT interval estimation.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2025

相关实验视频

Updated: Sep 13, 2025

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

378

整合Ga-PSMA-11 PET/CT与临床风险因素,提高前列腺癌进展预测.

Joanna M Wybranska1, Lorenz Pieper1, Christian Wybranski1

  • 1Division of Nuclear Medicine, Department of Radiology & Nuclear Medicine, Faculty of Medicine, Otto von Guericke University Magdeburg, 39120 Magdeburg, Germany.

Cancers
|July 29, 2025
PubMed
概括
此摘要是机器生成的。

将-68 PSMA-11 PET/CT成像生物标志物与临床因素结合起来,显著改善了高风险前列腺癌 (PCa) 患者早期复发的预测. 机器学习模型增强了个性化治疗策略的风险分层.

关键词:
68Ga-PSMA-11 聚乙烯 / 聚乙烯 / 聚乙烯 / 聚乙烯在CAPRA分数中,CAPRA的分数是什么?这是一辆SUVmax,SUVmax.早期生化复发的早期生化复发结果预测结果预测.前列腺癌是前列腺癌.

更多相关视频

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
09:11

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy

Published on: April 9, 2019

21.7K
A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

10.1K

相关实验视频

Last Updated: Sep 13, 2025

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

378
Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
09:11

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy

Published on: April 9, 2019

21.7K
A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

10.1K

科学领域:

  • 核医学就是核医学.
  • 在瘤学瘤学.
  • 机器学习在医学中的应用

背景情况:

  • 高风险前列腺癌 (PCa) 需要准确预测早期生化复发 (eBCR) 或治疗后临床进展.
  • 当前的风险分层工具可能会从集成先进的成像生物标志物中受益.
  • Ga-PSMA-11 PET/CT提供了前列腺癌扩散的详细成像.

研究的目的:

  • 评估是否将Ga-PSMA-11 PET/CT成像生物标志物与临床风险因素结合起来可以改善eBCR或高风险PCa临床进展的预测.
  • 开发和比较机器学习 (ML) 模型,以提高预测准确度.
  • 评估这些模型在指导个性化治疗决策方面的有用性.

主要方法:

  • 分析了接受Ga-PSMA-11 PET/CT和初级治疗的93名高风险PCa患者的数据.
  • 开发了两个预测模型:基于一个纯粹的贝叶斯框架的逻辑回归 (LR) 和概率图形模型 (PGM).
  • 输入变量根据统计分析,领域专业知识,文献评论和专家输入选择;与CAPRA风险评分进行比较.

主要成果:

  • 确定了关键预测因素:二元化CAPRA得分,最大的前列腺内PSMA吸收 (SUVmax),骨转移,结节参与和精液囊透.
  • 与LR (0.50) 和CAPRA得分 (0.59) 相比,PGM显示出更高的性能 (平衡精度:0.73).
  • 来自PGM的决策树提供了一个可解释的分类器,优先考虑CAPRA得分,SUVmax和PET检测到的瘤部位.

结论:

  • 将Ga-PSMA-11成像生物标志物与临床参数集成,显著提高了高风险PCa进展的预测模型.
  • 该PGM提供卓越的平衡精度和有效的风险分层.
  • 这些发现支持使用高级成像和ML用于PCa.个性化治疗策略.